Palyon Medical Corp — Form D/A
Palyon Medical Corp of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2009-08-10. The offering totals $24.0M, of which $24.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-08-10
- Form: D/A
- Accession: 0001463570-09-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $24.0M
- Amount sold: $24.0M
- Investors: 11
- Date of first sale: 2009-04-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-130784
Issuer
- Name: Palyon Medical Corp
- CIK: 0001463570
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 250 W. 57TH STREET, SUITE 1716, NEW YORK, NY, 10107
- Phone: 212-333-2050
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Gregory David | Director | New York, NY |
| Glen Kashuba | Director | Westminster, CO |
| Aidan King | Director | Dublin, L2 |
| Michael Liang | Director | Chicago, IL |
| Daniel Omstead | Director | Boston, MA |
| David Present | Director | Saint Louis, MO |
| Gregory David | Executive Officer | New York, NY |
| Cherine Plumaker | Executive Officer | Saint Louis, MO |
| David Present | Executive Officer | Saint Louis, MO |
Other filings by this issuer (1)
More